Pulse Biosciences, Inc.
PLSE
$13.18
-$0.07-0.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 86.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.00K | -- | -- | -- | -- |
| Cost of Revenue | 279.00K | -- | -- | -- | -- |
| Gross Profit | -193.00K | -- | -- | -- | -- |
| SG&A Expenses | 34.30M | 31.47M | 27.78M | 23.92M | 19.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 79.03M | 72.24M | 63.69M | 56.26M | 48.53M |
| Operating Income | -78.95M | -72.24M | -63.69M | -56.26M | -48.53M |
| Income Before Tax | -74.73M | -68.03M | -60.24M | -53.59M | -46.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -74.73 | -68.03 | -60.24 | -53.59 | -46.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.73M | -68.03M | -60.24M | -53.59M | -46.13M |
| EBIT | -78.95M | -72.24M | -63.69M | -56.26M | -48.53M |
| EBITDA | -77.85M | -71.10M | -62.52M | -55.08M | -47.33M |
| EPS Basic | -1.14 | -1.06 | -0.97 | -0.90 | -0.80 |
| Normalized Basic EPS | -0.71 | -0.66 | -0.61 | -0.56 | -0.50 |
| EPS Diluted | -1.14 | -1.06 | -0.97 | -0.90 | -0.80 |
| Normalized Diluted EPS | -0.71 | -0.66 | -0.61 | -0.56 | -0.50 |
| Average Basic Shares Outstanding | 263.84M | 257.52M | 247.43M | 237.43M | 230.43M |
| Average Diluted Shares Outstanding | 263.84M | 257.52M | 247.43M | 237.43M | 230.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |